Your browser doesn't support javascript.
loading
Suppression of tumorigenicity-2 (ST2) is a promising biomarker in heart transplantation.
Galeone, Antonella; Salem, Joe-Elie; Lebreton, Guillaume; Coutance, Guillaume; Nguyen, Lee; Hulot, Jean Sébastien; Atassi, Fabrice; Bega, Marco; Leprince, Pascal; Varnous, Shaida.
Afiliación
  • Galeone A; Department of Thoracic and Cardiovascular Surgery, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique des Hôpitaux de Paris, Sorbonne Université, Paris, France.
  • Salem JE; Department of Pharmacology and Clinical Investigation Center, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique des Hôpitaux de Paris, Sorbonne Université, Paris, France.
  • Lebreton G; Department of Thoracic and Cardiovascular Surgery, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique des Hôpitaux de Paris, Sorbonne Université, Paris, France.
  • Coutance G; Department of Thoracic and Cardiovascular Surgery, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique des Hôpitaux de Paris, Sorbonne Université, Paris, France.
  • Nguyen L; Department of Pharmacology and Clinical Investigation Center, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique des Hôpitaux de Paris, Sorbonne Université, Paris, France.
  • Hulot JS; Sorbonne Université, INSERM, Research unit on cardiovascular, metabolic and nutrition diseases, (UMRS-1166), Institute of Cardiometabolism and Nutrition Paris, Paris, France.
  • Atassi F; Sorbonne Université, INSERM, Research unit on cardiovascular, metabolic and nutrition diseases, (UMRS-1166), Institute of Cardiometabolism and Nutrition Paris, Paris, France.
  • Bega M; Department of Thoracic and Cardiovascular Surgery, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique des Hôpitaux de Paris, Sorbonne Université, Paris, France.
  • Leprince P; Department of Thoracic and Cardiovascular Surgery, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique des Hôpitaux de Paris, Sorbonne Université, Paris, France.
  • Varnous S; Department of Thoracic and Cardiovascular Surgery, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique des Hôpitaux de Paris, Sorbonne Université, Paris, France.
Clin Transplant ; 36(5): e14616, 2022 05.
Article en En | MEDLINE | ID: mdl-35188995
BACKGROUND: To evaluate the association between donors' and recipients' serum levels of soluble ST2 (sST2) and recipients' outcome after heart transplantation (HT). METHODS: Blood samples were collected in 50 heart donors before organ procurement and in 50 recipients before HT (D0), a week after HT (D7) and at every first year's endomyocardial biopsy (EMB); sST2 levels were evaluated by ELISA. RESULTS: Donors who sustained a cardiac arrest, had significantly higher sST2 levels. Recipients on national high emergency waiting list had significantly higher preoperative sST2 levels compared to recipients who did not. Recipients with postoperative sepsis or continuous renal replacement therapy had significantly higher sST2 levels at D7. Recipients who needed a postoperative ECMO for allograft dysfunction had significantly higher sST2 levels in their corresponding donors. Recipients who died during the hospitalization after the transplantation had significantly higher sST2 levels at D7 compared to recipients who did not. No difference was observed in sST2 levels in recipients who had mild allograft rejection and recipient who did not. CONCLUSIONS: Higher sST2 levels in donors are associated to allograft dysfunction requiring ECMO in recipients; higher postoperative sST2 levels in recipients are associated with in-hospital mortality.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Corazón / Proteína 1 Similar al Receptor de Interleucina-1 Límite: Humans Idioma: En Revista: Clin Transplant Asunto de la revista: TRANSPLANTE Año: 2022 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Dinamarca

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Corazón / Proteína 1 Similar al Receptor de Interleucina-1 Límite: Humans Idioma: En Revista: Clin Transplant Asunto de la revista: TRANSPLANTE Año: 2022 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Dinamarca